Page last updated: 2024-10-18

dalteparin and Alopecia

dalteparin has been researched along with Alopecia in 4 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Alopecia: Absence of hair from areas where it is normally present.

Research Excerpts

ExcerptRelevanceReference
" Alopecia has been reported as a side effect of LMWHs dalteparin and tinzaparin."3.73Enoxaparin-induced alopecia in patients with cerebral venous thrombosis. ( Po, HL; Wang, YY, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, YY1
Po, HL1
Barnes, C1
Deidun, D1
Hynes, K1
Monagle, P1
Apsner, R1
Hörl, WH1
Sunder-Plassmann, G1
Sarris, E1
Tsele, E1
Bagiatoudi, G1
Salpigidis, K1
Stavrianaki, D1
Kaklamanis, L1
Siakotos, M1

Other Studies

4 other studies available for dalteparin and Alopecia

ArticleYear
Enoxaparin-induced alopecia in patients with cerebral venous thrombosis.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:5

    Topics: Adult; Alopecia; Anticoagulants; Enoxaparin; Female; Humans; Intracranial Thrombosis; Middle Aged

2006
Alopecia and dalteparin: a previously unreported association.
    Blood, 2000, Aug-15, Volume: 96, Issue:4

    Topics: Alopecia; Anticoagulants; Child; Dalteparin; Female; Humans; Venous Thrombosis

2000
Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation.
    Blood, 2001, May-01, Volume: 97, Issue:9

    Topics: Alopecia; Anticoagulants; Citrates; Dalteparin; Female; Humans; Renal Dialysis

2001
Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:5

    Topics: Aged; Alopecia; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic;

2003